Therefore, Clinical strategies should focus on intensive diabetes management (target HbA1c < 7.0%), hypertension control (< 130/80 mmHg) using renin-angiotensin inhibitors and fluid management to prevent endothelial dysfunction. This evidence concerns the gene REN and diabetes mellitus.